Combating Antimicrobial Resistance (AMR) in India: Institutional and Policy Challenges
Antimicrobial Resistance (AMR) represents a critical crossroads of public health and governance, highlighting the tension between preventive healthcare measures and unchecked antibiotic misuse across human, animal, and plant ecosystems. The overuse of advanced antibiotics, such as ceftazidime-avibactam, underlines failures in regulatory oversight and policy enforcement. India, bearing one of the highest global burdens of bacterial infections, faces an escalating crisis as AMR increasingly threatens the effectiveness of standard treatment protocols, imposing severe social and economic costs.
UPSC Relevance Snapshot
- GS Paper III – Science and Technology: Awareness in health-related technical developments, challenges in regulatory policies.
- GS Paper II – Governance: Public health governance, global health collaboration mechanisms.
- Essay: Topics on "Healthcare Crisis Management" and "Balancing Development and Sustainability in Public Health Interventions."
Institutional Framework for Combating AMR in India
The challenge of AMR in India operates within a fragmented health governance system that requires synergies across human health, veterinary health, and environmental policies. Institutions such as the Indian Council of Medical Research (ICMR) and the National Centre for Disease Control (NCDC) have advanced surveillance mechanisms, but implementation gaps persist at state and local governance levels, particularly in enforcing antimicrobial stewardship programs (ASPs).
- Indian Council of Medical Research (ICMR): Implements Antimicrobial Stewardship Programs (ASPs) in tertiary hospitals and monitors drug resistance trends via genomic surveillance programs.
- National Centre for Disease Control (NCDC): Leads the National Action Plan for AMR (NAP-AMR) and provides coordination across human, animal, and agriculture sectors.
- Indian Council of Agricultural Research (ICAR): Focuses on reducing misuse of antimicrobials in livestock and promoting sustainable alternatives like insect-based feed.
- Policy Tools: Red Line Campaign for public awareness, bio-labeling mechanisms for antibiotics, and the DCGI's regulatory oversight.
Key Issues and Challenges
1. Awareness and Behavioural Challenges
- Lack of awareness about AMR among healthcare providers and patients leads to misuse of antibiotics. WHO categorizes India as having high antibiotic consumer mismanagement.
- NITI Aayog highlights insufficient community-level behavioural campaigns, despite efforts like the Red Line Campaign.
2. Regulatory and Institutional Gaps
- Weak enforcement: DCGI lacks the capacity to monitor antibiotic over-the-counter sales effectively, despite legal provisions under the Drugs and Cosmetics Act, 1940.
- Veterinary sector: Limited policies on antimicrobial use in livestock, with agricultural antibiotics constituting ~63% of total consumption globally (ICMR data).
3. Infrastructure Constraints
- Laboratory capacity: Only 5% of secondary healthcare institutions in India are equipped for AMR diagnostic testing (CAG, 2023).
- Sanitation and water: Poor WASH (Water, Sanitation, and Hygiene) infrastructure contributes significantly to infection spread, particularly in rural India.
4. Socioeconomic Barriers
- Economic burden: Longer hospital stays due to multidrug-resistant infections increase healthcare costs disproportionately for low-income families (World Bank estimates).
- Livelihood pressures: Overuse of growth-promoting antibiotics is prevalent among resource-constrained farmers to sustain livestock productivity.
Comparative Table: India vs United States on AMR Containment
| Parameter | India | United States |
|---|---|---|
| Antibiotic Regulatory Availability | Weak enforcement of prescription-only sales | Strict pharmacy licensing and penalties under FDA |
| Antibiotic Stewardship Programs | Implemented in tertiary facilities but no rural reach | Operational across all healthcare levels (CDC program) |
| AMR Surveillance Network | ICMR's Genomic Surveillance; urban dominance | Comprehensive CDC AMR surveillance data |
| Policy Intervention Indicators | National Action Plan on AMR, lagging state-level adoption | High compliance under Federal AMR Action Plan |
Critical Evaluation
While India's institutional response, led by ICMR and NCDC, showcases commendable progress, systemic, and societal gaps hinder comprehensive success. The WHO Global Action Plan on AMR emphasizes a ‘One Health’ approach, harmonizing human, animal, and environmental health. However, India’s execution remains limited in reducing over-the-counter drug sales and implementing preventive measures in agriculture. Furthermore, while innovation in antibiotics like cefepime-zidebactam highlights India's biotech potential, the commercialization of these drugs without strong stewardship provisions risks a recurrence of resistance.
Global lessons, particularly from countries like the USA, highlight the importance of bottom-up compliance, robust public surveillance, and stringent law enforcement. India's policy ecosystem must balance high drug accessibility with significant strengthening of prescriptive controls and rural health infrastructure.
Structured Assessment
- Policy Design Adequacy: The National Action Plan on AMR is theoretically sound but suffers from slow, uneven multi-sectoral adoption.
- Governance and Institutional Capacity: While agencies like ICMR excel in research, weaker state-level implementation and regulatory fragmentation dilute outcomes.
- Behavioural and Structural Issues: Socioeconomic inequities, weak public awareness campaigns, and WASH deficits exacerbate AMR risks, particularly in rural contexts.
Practice Questions
- Which of the following best describes Antimicrobial Resistance (AMR)?
Options:
A. Natural biological resistance of bacteria to immune responses.
B. Inability of antimicrobials to treat infections due to pathogen adaptation.
C. Adverse effects caused by excessive use of biologically-derived drugs.
D. Long-term dependency on advanced antibiotics for minor illnesses.
Answer: B - "Red Line Campaign" in India aims to:
Options:
A. Ban the sale of generic antibiotics in rural areas.
B. Label prescription-only antibiotics to prevent over-the-counter availability.
C. Introduce new high-potency antibiotics for resistant infections.
D. Establish tertiary diagnostic centers for AMR surveillance.
Answer: B
Practice Questions for UPSC
Prelims Practice Questions
- AMR primarily arises from the overuse of antibiotics in the medical sector only.
- India has one of the highest burdens of bacterial infections globally.
- The Indian Council of Medical Research (ICMR) is involved in AMR genomic surveillance.
Which of the above statements is/are correct?
- Weak enforcement of pharmaceutical regulations.
- High public awareness regarding antibiotic misuse.
- Low capacity for AMR diagnostic testing in healthcare facilities.
- Socioeconomic barriers affecting access to healthcare.
Select the correct option.
Frequently Asked Questions
What is Antimicrobial Resistance (AMR) and why is it a critical issue in India?
Antimicrobial Resistance (AMR) is the reduced effectiveness of antibiotics due to their overuse and misuse in various sectors. In India, AMR poses a significant threat to public health as it increases the burden of bacterial infections, complicating treatment protocols and escalating healthcare costs.
What institutions are primarily involved in combating AMR in India?
Key institutions include the Indian Council of Medical Research (ICMR), which conducts genomic surveillance and implements Antimicrobial Stewardship Programs (ASPs), and the National Centre for Disease Control (NCDC), which coordinates the National Action Plan for AMR across multiple sectors.
What are some major challenges India faces in addressing AMR?
India grapples with several challenges including weak regulatory enforcement regarding antibiotic sales, insufficient awareness among healthcare providers and patients, and limited laboratory infrastructure capable of AMR testing. Additionally, socioeconomic factors exacerbate the situation, particularly affecting low-income populations.
How does India's approach to AMR compare with that of the United States?
While India has made strides through programs like the National Action Plan on AMR, its enforcement and reach lag behind the USA, which implements comprehensive AMR strategies across all healthcare levels. The lack of rural outreach in India contrasts with the structured compliance and operational efficiency seen in the U.S. approach.
What strategies are suggested to enhance the fight against AMR in India?
Strategies include enhancing public awareness through behavioral campaigns, improving regulatory frameworks for antibiotic sales, and strengthening collaboration among health sectors. The implementation of targeted educational programs and sustainable agricultural practices is also crucial to mitigate the misuse of antibiotics.
Source: LearnPro Editorial | Daily Current Affairs | Published: 25 April 2025 | Last updated: 3 March 2026
About LearnPro Editorial Standards
LearnPro editorial content is researched and reviewed by subject matter experts with backgrounds in civil services preparation. Our articles draw from official government sources, NCERT textbooks, standard reference materials, and reputed publications including The Hindu, Indian Express, and PIB.
Content is regularly updated to reflect the latest syllabus changes, exam patterns, and current developments. For corrections or feedback, contact us at admin@learnpro.in.